Product Reports Resources Pricing Login Book a demo

NowRx

Biotech & Life Sciences · Mountain View, United States · Founded 2015

A pharmacy and last-mile logistics company that provides same-day and same-hour prescription medication delivery MoreLess

NowRx operates as a technology-driven pharmacy, aiming to overhaul the traditional retail pharmacy experience through a model centered on efficiency and convenience. The company was co-founded in 2015 by CEO Cary Breese and CTO Sumeet Sheokand. Breese, a multi-time CEO with a background in leading tech startups that disrupt legacy industries, and Sheokand conceived the business plan after recognizing the inefficiency of waiting in line at a pharmacy. They launched their first fulfillment center in January 2016.

The business functions by eliminating physical retail locations and instead uses low-cost, highly automated micro-fulfillment centers. This strategy allows NowRx to offer free, same-day delivery for prescription medications. For more urgent needs, an expedited one-hour delivery is available for a $5 fee. Revenue is generated from payments for prescription and over-the-counter items, with the company accepting most major insurance plans and charging customers their standard co-pay. The target market consists of any consumer who uses a retail pharmacy, particularly those who value the convenience of home delivery, such as patients with chronic conditions or those wishing to avoid exposure in crowded pharmacies.

At the core of NowRx's operation is its proprietary pharmacy management software, QuickFill. This system automates many aspects of the prescription process, including billing, insurance verification, and fulfillment coordination. When a doctor sends a prescription, NowRx's system processes it, and robots can sort, count, bottle, and label the medication in under 30 seconds. The platform also includes a consumer-facing app for tracking orders and a logistics app called Wheelz for its HIPAA-trained drivers. Beyond prescription delivery, the company expanded its offerings to include telehealth services, starting with NowPrEP, a service for pre-exposure prophylaxis that includes physician assessment, lab testing, and home delivery. In November 2022, Alto Pharmacy acquired NowRx's patient files in California.

Keywords: digital pharmacy, prescription delivery, pharmacy automation, telehealth services, micro-fulfillment, on-demand prescriptions, Cary Breese, Sumeet Sheokand, QuickFill, medication delivery, last-mile logistics, online pharmacy, robotic dispensing, pharmacy software, healthcare technology, e-pharmacy, prescription management, home delivery pharmacy, NowPrEP, telehealth pharmacy

Valuation $100–500M
Revenue $10–50M
Headcount <100
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for NowRx and the history behind them.

Company overview

NowRx company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
Mountain View, United States
Employees
15
Open positions
None listed
Dealroom signal
63.3
sub industryPharmaceuticalsub industryHealth Platformbusiness modelMarketplace & ecommerceindustryHealthsectorPharmacysectorRetailsectorBiotechnologysectorSurgerysectorBiotech and Pharmaclient focusb2c

Valuation & funding

NowRx funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing May 2022 $24M $275M Seedinvest
SERIES COther financing Oct 2021 $73M $275M Seedinvest
SERIES BOther financing Jul 2020 $20M $65M Seedinvest
SERIES BOther financing Apr 2020 $8.5M $65M Seedinvest
SERIES AOther financing Oct 2019 $700K $65M Undisclosed
SERIES AOther financing Oct 2018 Seedinvest
SERIES AOther financing Jul 2018 Crowdcube · Seedinvest
SERIES AOther financing Jan 2018 Undisclosed
SEEDOther financing Jun 2017 Seedinvest
Showing 9 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $11M 0% 15
2025 $11M 0% 15
2024 $11M 0% 16
2023 $11M 0% 22
2022 $11M +38.3% 67
2021 $7.8M +62.7% 63
2020 $4.8M 49
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

NowRx website traffic

Latest recorded traffic for NowRx is 2.2K monthly website visits, up 780% over the last three months. NowRx's team grew 0% over the past year.

Latest monthly visits2.2K 3-month web change+780% 1-year team growth0%
Monthly website visits91 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

NowRx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

NowRx's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on NowRx's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Seedinvest
Series A 1 investor entered at this stage

Global footprint

Where NowRx has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States83.3%
🇬🇧 United Kingdom16.7%
2 countries shown

In the news

Latest news about NowRx

Recent press, funding announcements, and product moves mentioning NowRx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about NowRx

An AI-synthesized read of the highest-engagement posts about NowRx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NowRx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.